BACKGROUND: Mitochondrial dysfunctions are implicated in the pathophysiology of mood disorders. We measured and examined the following selected mitochondrial parameters: citrate synthase (CS) activity, electron transport system (ETS) complex (complexes I, II, and IV) activities, and mitochondrial respiration in blood platelets. PATIENTS AND METHODS: The analyses were performed for 24 patients suffering from a depressive episode of bipolar affective disorder (BD), compared to 68 patients with MDD and 104 healthy controls. BD and unipolar depression were clinically evaluated using well-established diagnostic scales and questionnaires. RESULTS: The CS, complex II, and complex IV activities were decreased in the depressive episode of BD patients; complex I and complex I/CS ratio were significantly increased compared to healthy controls. We observed significantly decreased complex II and CS activities in patients suffering from MDD compared to controls. Decreased respiration after complex I inhibition and increased residual respiration were found in depressive BD patients compared to controls. Physiological respiration and capacity of the ETS were decreased, and respiration after complex I inhibition was increased in MDD patients, compared to controls. Increased complex I activity can be a compensatory mechanism for decreased CS and complex II and IV activities. CONCLUSION: We can conclude that complex I and its abnormal activity contribute to the defects in cellular energy metabolism during a depressive episode of BD. The observed parameters could be used in a panel of biomarkers that could selectively distinguish BD depression from MDD and can be easily examined from blood elements.

Department of Pediatrics and Adolescent Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague 120 00 Prague 2 Czech Republic

Department of Psychiatry 1st Faculty of Medicine Charles University and General University Hospital Prague 120 00 Prague 2 Czech Republic

Institute of Pharmacology 1st Faculty of Medicine Charles University and General University Hospital Prague 128 00 Prague 2 Czech Republic

Zobrazit více v PubMed

Cikánková T, Sigitova E, Zverova M, Fisar Z, Raboch J, Hroudova J. Mitochondrial dysfunctions in bipolar disorder: Effect of the disease and pharmacotherapy. CNS Neurol Disord Drug Targets. 2017;16(2):176–186. PubMed

Harrison PJ, Geddes JR, Tunbridge EM. The emerging neurobiology of bipolar disorder. Trends Neurosci. 2018;41(1):18–30. PubMed PMC

Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet. 2016;387(10027):1561–1572. PubMed

Phillips ML, Kupfer DJ. Bipolar disorder diagnosis: challenges and future directions. Lancet. 2013;381(9878):1663–1671. PubMed PMC

Cuellar AK, Johnson SL, Winters R. Distinctions between bipolar and unipolar depression. Clin Psychol Rev. 2005;25(3):307–339. PubMed PMC

Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003;64(2):161–174. PubMed

Shao L, Martin MV, Watson SJ, et al. Mitochondrial involvement in psychiatric disorders. Ann Med. 2008;40(4):281–295. PubMed PMC

Shen H, Zhang L, Xu C, Zhu J, Chen M, Fang Y. Analysis of misdiagnosis of bipolar disorder in an outpatient setting. Shanghai Arch Psychiatry. 2018;30(2):93–101. PubMed PMC

Parker G, McCraw S, Hadzi-Pavlovic D, Fletcher K. Costs of the principal mood disorders: a study of comparative direct and indirect costs incurred by those with bipolar I, bipolar II and unipolar disorders. J Affect Disord. 2013;149(1–3):46–55. PubMed

Bartoli F, Crocamo C, Clerici M, Carrà G. Allopurinol as add-on treatment for mania symptoms in bipolar disorder: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry. 2017;210(1):10–15. PubMed

Bartoli F, Trotta G, Crocamo C, Malerba MR, Clerici M, Carrà G. Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression. Eur Arch Psychiatry Clin Neurosci. 2018;268(2):119–127. PubMed

Morris G, Walder K, McGee SL, et al. A model of the mitochondrial basis of bipolar disorder. Neurosci Biobehav Rev. 2017;74(Pt A):1–20. PubMed

Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EL. Mitochondrial dysfunction and psychiatric disorders. Neurochem Res. 2009;34(6):1021–1029. PubMed

Jou SH, Chiu NY, Liu CS. Mitochondrial dysfunction and psychiatric disorders. Chang Gung Med J. 2009;32(4):370–379. PubMed

Schapira AH, Diseases M. Mitochondrial diseases. Lancet. 2012;379(9828):1825–1834. PubMed

Stork C, Renshaw PF. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry. 2005;10(10):900–919. PubMed

Yildiz-Yesiloglu A, Ankerst DP. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(6):969–995. PubMed

de Sousa RT, Streck EL, Forlenza OV, et al. Regulation of leukocyte tricarboxylic acid cycle in drug-naïve bipolar disorder. Neurosci Lett. 2015;605:65–68. PubMed PMC

Rollins BL, Morgan L, Hjelm BE, et al. Mitochondrial complex I deficiency in schizophrenia and bipolar disorder and medication influence. Mol Neuropsychiatry. 2018;3(3):157–169. PubMed PMC

Clay HB, Sillivan S, Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci. 2011;29(3):311–324. PubMed PMC

Fox JE, Reynolds CC, Boyles JK. Studying the platelet cytoskeleton in Triton X-100 lysates. Methods Enzymol. 1992;215:42–58. PubMed

Fišar Z, Hroudová J, Hansíková H, et al. Mitochondrial respiration in the platelets of patients with Alzheimer’s disease. Curr Alzheimer Res. 2016;13(8):930–941. PubMed

Böhm M, Papezova H, Hansikova H, Wenchich L, Zeman J. Activities of respiratory chain complexes in isolated platelets in females with anorexia nervosa. Int J Eat Disord. 2007;40(7):659–663. PubMed

Rustin P, Chretien D, Bourgeron T, et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta. 1994;228(1):35–51. PubMed

Hroudova J, Fisar Z. Activities of respiratory chain complexes and citrate synthase influenced by pharmacologically different antidepressants and mood stabilizers. Neuroendocrinology Letters. 2010;31(3):336–342. PubMed

Diab YA, Thomas A, Luban NL, Wong EC, Wagner SJ, Levy RJ. Acquired cytochrome C oxidase impairment in apheresis platelets during storage: a possible mechanism for depletion of metabolic adenosine triphosphate. Transfusion. 2012;52(5):1024–1030. PubMed

Renner K, Amberger A, Konwalinka G, Kofler R, Gnaiger E. Changes of mitochondrial respiration, mitochondrial content and cell size after induction of apoptosis in leukemia cells. Biochim Biophys Acta. 2003;1642(1–2):115–123. PubMed

Stadlmann S, Renner K, Pollheimer J, et al. Preserved coupling of oxidative phosphorylation but decreased mitochondrial respiratory capacity in IL-1beta-treated human peritoneal mesothelial cells. Cell Biochem Biophys. 2006;44(2):179–186. PubMed

Sjövall F, Morota S, Hansson MJ, Friberg H, Gnaiger E, Elmér E. Temporal increase of platelet mitochondrial respiration is negatively associated with clinical outcome in patients with sepsis. Crit Care. 2010;14(6):R214. PubMed PMC

R Core Team . A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2017.

Sjövall F, Ehinger JK, Marelsson SE, et al. Mitochondrial respiration in human viable platelets – methodology and influence of gender, age and storage. Mitochondrion. 2013;13(1):7–14. PubMed

Wang L, Wu Q, Fan Z, Xie R, Wang Z, Lu Y. Platelet mitochondrial dysfunction and the correlation with human diseases. Biochem Soc Trans. 2017;45(6):1213–1223. PubMed

Lim SC, Hroudová J, van Bergen NJ, Lopez Sanchez MI, Trounce IA, McKenzie M. Loss of mitochondrial DNA-encoded protein ND1 results in disruption of complex I biogenesis during early stages of assembly. FASEB J. 2016;30(6):2236–2248. PubMed

Hroudová J, Fišar Z. In vitro inhibition of mitochondrial respiratory rate by antidepressants. Toxicol Lett. 2012;213(3):345–352. PubMed

Gardner A, Johansson A, Wibom R, et al. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J Affect Disord. 2003;76(1–3):55–68. PubMed

Age-Dependent Alterations in Platelet Mitochondrial Respiration

Measurement of Mitochondrial Respiration in Platelets